Our Partners











Dublin Consensus Statement 2011


The CHS and NRBDO support Dublin Consensus Statement

Montreal – June 11, 2011
– The Blood Safety and Supply Committee of the Canadian Hemophilia Society and the Network of Rare Blood Disorder Organizations (NRBDO) have endorsed the 2011 Dublin Consensus Statement on the collection and provision of blood components and plasma derived medicinal products (PDMPs).

The Consensus Statement was developed in January 2011 at a meeting in Dublin, Ireland, that brought together representatives of patient groups, blood donor associations, not-for-profit blood collectors and manufacturers, and for-profit manufacturers.

A meeting held In January 2010 set the stage for achieving the broad consensus.

The Dublin Consensus Statement recognizes two major priorities for the global community in providing patients with adequate and safe blood components and PDMPs: 1) to provide and maintain safe, sustainable and sufficient blood components in all countries through the development of national blood transfusion systems based on voluntary non-remunerated donors; 2) provide an adequate supply of PDMPs from recovered and source plasma to meet patient needs on a global level.

The Statement includes principles related to patients, donors, cooperation between systems that collect blood and plasma from both remunerated and non-remunerated donors, and global utilization of donated blood and plasma.

Since the meeting in January, the governing bodies of a broad range of patient, donor and blood system organizations have endorsed the Statement.

Click here for full statement.